参考文献/References:
[1]Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group.Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)[J].Hum Reprod,2004,19(1):41-47.[2]Zhao X,Ni R,Li L,et al.Defining hirsutism in Chinese women:across-sectional study[J].Fertil&Steril,2011,96(3):792-796.[3]Matthews DR,Hosker JP,Rudenski AS,et al.Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man[J].Diabetologia,1985,28(7):412-419.[4]Abbasi F,Silvers A,Viren J,et al.Relationship between several surrogate estimates of insulin resistance and a direct measure of insulin mediated glucose disposal:Comparison of fasting versus post glucose load measurements[J].Diabetes Res Clin Pract,2018,136:108-115. [5]Escobar-Morreale HF.Polycystic ovary syndrome:definition,aetiology, diagnosis and treatment[J].Nat Rev Endocrinol,2018,14(5):270-284. [6]Bastard JP,Maachi M,Lagathu C,et al.Recent advances in the relationship between obesity, inflammation, and insulin resistance[J].Eur Cytokine Netw,2006,17(1):4-12.[7]Pasquali R.Metabolic syndrome in polycystic ovary syndrome[J].Front Horm Res,2018,49:114-130. [8]谢应朗,陈发荣,杨敏,等.CT定量测量腹部脂肪面积的研究[J].实用放射学杂志,2000,16(1):43-45.[9]陈丽,兰珍,张丹.不同肥胖标准在评估多囊卵巢综合征胰岛素抵抗中的价值[J].四川大学学报(医学版),2013,44(6):945-949.[10]Diamanti-Kandarakis E,Dunaif A.Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications[J].Endocr Rev,2012,33(6):981-1030. [11]Leerasiri P,Wongwananuruk T,Indhavivadhana S,et al.Correlation of clinical and biochemical hyperandrogenism in Thai women with polycystic ovary syndrome[J].J Obstet Gynaecol Res,2016,42(6):678-683.[12]Teede HJ,Misso ML,Costello MF,et al.International PCOS Network. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome[J].Hum Reprod,2018,33(9):1602-1618.[13]Uysal G,Sahin Y,Unluhizarci K,et al.Is acne assign of androgen excess disorder or not[J].Eur J Obstet Gynecol Reprod Biol,2017,211:21-25. [14]朱茜,倪郝,全松.多囊卵巢综合征高雄激素特征及管理[J].中国实用妇科与产科杂志,2019,35(3):274-278.[15]崔琳琳,陈子江.多囊卵巢综合征诊断标准和诊疗指南介绍[J].国际生殖健康/计划生育杂志,2011,30(5):405-408.[16]刘丽,邵洁白,张红萍,等.不同表型多囊卵巢综合征患者的代谢特征[J].全科医学临床与教育,2011,9(5):505-507.[17]Hu H,Kurotani K,Sasaki N,et al.Optimal waist circumference cut-off points and ability of different metabolic syndrome criteria for predicting diabetes in Japanese men and women: Japan Epidemiology Collaboration on Occupational Health[J].Study BMC Public Health,2016,16:220. [18]Williams T,Mortada R,Porter S.Diagnosis and Treatment of Polycystic Ovary Syndrome[J].American Family Physician,2016,94(2):106-113.[19]Gourgari E,Lodish M,Shamburek R,et al.Lipoprotein particles in adolescents and young women with PCOS provide insights into their cardiovascular risk[J].J Clin Endocrinol Metab,2015,100(11):4291-4298.[20]张凤,刘宏伟.多囊卵巢综合征脂类代谢异常及其治疗[J].国际生殖健康/计划生育杂志,2011,30:126-128. [21]Peigné M,Dewailly D.Long term complications of polycystic ovary syndrome (PCOS)[J].Ann Endocrinol,2014,75(4):194-199.
相似文献/References:
[1]袁 奔,潘 伟,罗淑红,等.体重指数对多囊卵巢综合征患者
人工授精妊娠结局影响[J].医学信息,2018,31(12):99.[doi:10.3969/j.issn.1006-1959.2018.12.030]
YUAN Ben,PAN Wei,LUO Shu-hong,et al.Effects of Body Mass Index on the Outcome of Artificial Insemination in Patients with Polycystic Ovary Syndrome[J].Medical Information,2018,31(12):99.[doi:10.3969/j.issn.1006-1959.2018.12.030]
[2]李德君,李慧君.来曲唑联合苍附导痰汤治疗多囊卵巢综合征不孕症患者的
临床观察[J].医学信息,2018,31(17):137.[doi:10.3969/j.issn.1006-1959.2018.17.043]
LI De-jun,LI Hui-jun.Clinical Observation of Letrozole Combined with Cangfu Daotan Decoction in the Treatment of Infertility Patients with Polycystic Ovary Syndrome[J].Medical Information,2018,31(12):137.[doi:10.3969/j.issn.1006-1959.2018.17.043]
[3]廖 霜.二甲双胍联合沙格列汀或格列美脲对新诊断合并腹型肥胖的2型糖尿病患者临床疗效对比[J].医学信息,2018,31(24):70.[doi:10.3969/j.issn.1006-1959.2018.24.018]
LIAO Shuang.Comparison of Clinical Efficacy of Metformin Combined with Salglutin or Glimepiride in Newly Diagnosed Type 2 Diabetic Patients with Abdominal Obesity[J].Medical Information,2018,31(12):70.[doi:10.3969/j.issn.1006-1959.2018.24.018]
[4]曾利文,陈 静,张 晔,等.多囊卵巢综合征患者的糖代谢特点分析[J].医学信息,2019,32(02):103.[doi:10.3969/j.issn.1006-1959.2019.02.029]
ZENG Li-wen,CHEN Jing,ZHANG Ye,et al.Analysis of Characteristics of Glucose Metabolism in Patients with Polycystic Ovarian Syndrome[J].Medical Information,2019,32(12):103.[doi:10.3969/j.issn.1006-1959.2019.02.029]
[5]谢 丹.不同促排卵方案治疗多囊卵巢综合征不孕症的效果[J].医学信息,2020,33(18):141.[doi:10.3969/j.issn.1006-1959.2020.18.046]
XIE Dan.The Effect of Different Ovulation Induction Programs on the Infertility of Polycystic Ovary Syndrome[J].Medical Information,2020,33(12):141.[doi:10.3969/j.issn.1006-1959.2020.18.046]
[6]王海燕,毕雪玲,曹 晶,等.坤泰胶囊联合炔雌醇环丙孕酮片、二甲双胍治疗多囊卵巢综合征的效果及对性激素的影响[J].医学信息,2020,33(20):129.[doi:10.3969/j.issn.1006-1959.2020.20.039]
WANG Hai-yan,BI Xue-ling,CAO Jing,et al.The Effect of Kuntai Capsule Combined with Ethinyl Estradiol and Cyproterone Tablets and Metformin in the Treatment of Polycystic Ovary Syndrome and Its Influence on Sex Hormones[J].Medical Information,2020,33(12):129.[doi:10.3969/j.issn.1006-1959.2020.20.039]
[7]王争艳,宋发荣.中药月经周期疗法治疗PCOS不孕症的效果[J].医学信息,2020,33(20):153.[doi:10.3969/j.issn.1006-1959.2020.20.048]
WANG Zheng-yan,SONG Fa-rong.The Effect of Chinese Medicine Menstrual Cycle Therapy on PCOS Infertility[J].Medical Information,2020,33(12):153.[doi:10.3969/j.issn.1006-1959.2020.20.048]
[8]朱 艳,周 琴,安 洁,等.脂联素基因单核苷酸多态性与多囊卵巢综合征伴胰岛素抵抗的关系研究[J].医学信息,2020,33(22):87.[doi:10.3969/j.issn.1006-1959.2020.22.025]
ZHU Yan,ZHOU Qin,AN Jie,et al.Study on the Relationship Between Adiponectin Gene Single Nucleotide Polymorphism and Polycystic Ovary Syndrome with Insulin Resistance[J].Medical Information,2020,33(12):87.[doi:10.3969/j.issn.1006-1959.2020.22.025]
[9]袁 瑞,余亚莉.吡格列酮二甲双胍片治疗胰岛素抵抗型多囊卵巢综合征患者的疗效[J].医学信息,2021,34(01):158.[doi:10.3969/j.issn.1006-1959.2021.01.043]
YUAN Rui,YU Ya-li.Efficacy of Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets in the Treatment of Patients with Insulin-resistant Polycystic Ovary Syndrome[J].Medical Information,2021,34(12):158.[doi:10.3969/j.issn.1006-1959.2021.01.043]
[10]覃德明,曾 辛,胡雪莉.多囊卵巢综合征患者生殖道微生态状况研究[J].医学信息,2021,34(09):73.[doi:10.3969/j.issn.1006-1959.2021.09.019]
QIN De-ming,ZENG Xin,HU Xue-li.Study on the Microecological Status of Reproductive Tract in Patients with Polycystic Ovary Syndrome[J].Medical Information,2021,34(12):73.[doi:10.3969/j.issn.1006-1959.2021.09.019]